Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer

BACKGROUND: A subset of men with metastatic prostate cancer (mPC) responds to immune checkpoint inhibitors, and there is an unmet need to predict those most likely to benefit. We characterized circulating tumor cells (CTCs) for expression of immune checkpoint ligands in men with mPC as a non-invasiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tian, Agarwal, Anika, Almquist, R. Garland, Runyambo, Daniella, Park, Sally, Bronson, Elizabeth, Boominathan, Rengasamy, Rao, Chandra, Anand, Monika, Oyekunle, Taofik, Healy, Patrick, McNamara, Megan A., Ware, Kathryn, Somarelli, Jason A., George, Daniel J., Armstrong, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890610/
https://www.ncbi.nlm.nih.gov/pubmed/33602330
http://dx.doi.org/10.1186/s40364-021-00267-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890610/
https://www.ncbi.nlm.nih.gov/pubmed/33602330
http://dx.doi.org/10.1186/s40364-021-00267-y

Ejemplares similares